FDA OKs Mepolizumab for Younger Children With Severe Asthma FDA OKs Mepolizumab for Younger Children With Severe Asthma

Nucala is the first biologic approved in the US for children aged 6 to 11 years with severe eosinophilic asthma.News Alerts
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Pulmonary Medicine News Alert Source Type: news